Chris Peetz

Chief Executive Officer · Mirum Pharmaceuticals

Pharma & Life SciencesNorth AmericaEstablished

Why follow Chris

Follow the Mirum chief executive for rare-disease drug development and commercial strategy, including the zilurgisertib program for fibrodysplasia ossificans progressiva.

Writes about

Rare diseaseDrug developmentBiopharma

Best for

Rare-disease biopharma operators